List of Studies ( Metabolite:Liquiritigenin)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Feces | Mouse | Dalian Institute Of Chemical Physics | blank-substracted abundances | |
ST001875 | AN003037 | Metabolomics analysis of multiple samples on AB 5600-Part 2 | Liver | Mouse | Dalian Institute Of Chemical Physics | blank-substracted abundances | |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST002711 | AN004394 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: biogenic amines | Blood | Human | Autism | Columbia University | normalized peak heights |
ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Blood | Human | Dalian Institute Of Chemical Physics | peak area | |
ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Hep G2 cells | Human | Dalian Institute Of Chemical Physics | peak area | |
ST001873 | AN003035 | Metabolomics analysis of multiple samples on AB 5600-Part 1 | Urine | Human | Dalian Institute Of Chemical Physics | peak area | |
ST002153 | AN003527 | Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 | Blood | Mouse | Morinaga milk industry CO., LTD. | peak area | |
ST001928 | AN003136 | Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype | Urine | Human | George Mason University | Peak height | |
ST002950 | AN004839 | Investigate the impact of feeding time on the hexosamine biosynthetic pathway (HBP) in the mouse liver and heart using targeted metabolomics: biogenic amines | Heart | Mouse | University of California, Davis | peak heights | |
ST002950 | AN004839 | Investigate the impact of feeding time on the hexosamine biosynthetic pathway (HBP) in the mouse liver and heart using targeted metabolomics: biogenic amines | Liver | Mouse | University of California, Davis | peak heights | |
ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed |